Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -8.63% is 57% above its 5-year average of -19.89%, near the high end of its 5-year range (-44.40%–-4.85%).
29.41% above its 12-month average of -12.23%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -4.85%.
OPERATING MARGIN
-8.63%
OPERATING MARGIN AVG TTM
-12.23%
OPERATING MARGIN AVG 3Y
-12.99%
OPERATING MARGIN AVG 5Y
-19.89%
OPERATING MARGIN AVG 10Y
-10.16%
OPERATING MARGIN AVG 15Y
-5.80%
OPERATING MARGIN AVG 20Y
-6.29%
CURRENT VS TTM AVG
+29.41%
CURRENT VS 3Y AVG
+33.56%
CURRENT VS 5Y AVG
+56.61%
CURRENT VS 10Y AVG
+15.02%
CURRENT VS 15Y AVG
-48.68%
CURRENT VS 20Y AVG
-37.25%
SECTOR MEDIAN · HEALTHCARE
13.86%
median of 98 covered companies
CURRENT VS SECTOR MEDIAN
-162.29%
vs the sector median at left
NeoGenomics, Inc.
Market Cap
$470.35M
Operating Margin
-8.63%
TTM Avg
-12.23%
3Y Avg
-12.99%
5Y Avg
-19.89%
Market Cap
$389.98M
Operating Margin
-58.53%
TTM Avg
-50.96%
3Y Avg
-52.76%
5Y Avg
-52.76%
Market Cap
$41.24M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.01B
Operating Margin
-6.98%
TTM Avg
-25.06%
3Y Avg
-156.73%
5Y Avg
-114.38%
Market Cap
$1.71B
Operating Margin
-651.67%
TTM Avg
-787.38%
3Y Avg
-968.58%
5Y Avg
-820.03%
Market Cap
$1.74B
Operating Margin
11.69%
TTM Avg
-8.16%
3Y Avg
-10.59%
5Y Avg
-4.68%
Market Cap
$2.13B
Operating Margin
-867.87%
TTM Avg
-840.98%
3Y Avg
-774.76%
5Y Avg
-1234.34%
Market Cap
$2.49B
Operating Margin
-274.57%
TTM Avg
-464.41%
3Y Avg
-382.79%
5Y Avg
-92575.80%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NeoGenomics, Inc. (NEO) | $470.35M | -8.63% | -12.23% | -12.99% | -19.89% |
| NRC Health (NRC)vs › | $459.30M | 10.53% | 20.52% | 24.67% | 27.45% |
| Shoulder Innovations, Inc. (SI)vs › | $389.98M | -58.53% | -50.96% | -52.76% | -52.76% |
| PDS Biotechnology Corporation (PDSB)vs › | $41.24M | 0.00% | 0.00% | 0.00% | 0.00% |
| Teladoc Health, Inc. (TDOC)vs › | $1.01B | -6.98% | -25.06% | -156.73% | -114.38% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | -651.67% | -787.38% | -968.58% | -820.03% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | 11.69% | -8.16% | -10.59% | -4.68% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.13B | -867.87% | -840.98% | -774.76% | -1234.34% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.49B | -274.57% | -464.41% | -382.79% | -92575.80% |
| TransMedics Group, Inc. (TMDX)vs › | $2.72B | 12.21% | 13.21% | -4.78% | -42.05% |
Gross Margin
42.9%
Operating Margin
-8.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -4.85% |
| 2026-03-31 | -9.77% |
| 2025-12-31 | -5.86% |
| 2025-09-30 | -14.38% |
| 2025-06-30 | -26.27% |
| 2025-03-31 | -16.56% |
| 2024-12-31 | -10.70% |
| 2024-09-30 | -12.63% |
| 2024-06-30 | -13.34% |
| 2024-03-31 | -19.56% |
| 2023-12-31 | -11.94% |
| 2023-09-30 | -15.92% |
| 2023-06-30 | -20.35% |
| 2023-03-31 | -25.56% |
| 2022-12-31 | -19.02% |
| 2022-09-30 | -30.68% |
| 2022-06-30 | -31.74% |
| 2022-03-31 | -44.40% |
| 2021-12-31 | -33.06% |
| 2021-09-30 | -32.73% |
| 2021-06-30 | -18.38% |
| 2021-03-31 | -13.08% |
| 2020-12-31 | 4.40% |
| 2020-09-30 | 3.72% |
| 2020-06-30 | -21.74% |
| 2020-03-31 | -4.99% |
| 2019-12-31 | 2.17% |
| 2019-09-30 | 3.50% |
| 2019-06-30 | 4.40% |
| 2019-03-31 | 2.67% |
| 2018-12-31 | 3.69% |
| 2018-09-30 | 5.67% |
| 2018-06-30 | 1.17% |
| 2018-03-31 | 3.95% |
| 2017-12-31 | 6.62% |
| 2017-09-30 | -3.65% |
| 2017-06-30 | 2.11% |
| 2017-03-31 | -0.19% |
| 2016-12-31 | -4.85% |
| 2016-09-30 | 2.30% |
| 2016-06-30 | 3.47% |
| 2016-03-31 | 3.22% |
| 2015-12-31 | -19.12% |
| 2015-09-30 | 0.45% |
| 2015-06-30 | 0.11% |
| 2015-03-31 | -2.44% |
| 2014-12-31 | 5.28% |
| 2014-09-30 | -0.31% |
| 2014-06-30 | 2.80% |
| 2014-03-31 | 2.17% |
| 2013-12-31 | 6.57% |
| 2013-09-30 | 6.87% |
| 2013-06-30 | 3.24% |
| 2013-03-31 | 1.95% |
| 2012-12-31 | 1.32% |
| 2012-09-30 | -4.82% |
| 2012-06-30 | 5.37% |
| 2012-03-31 | 5.68% |
| 2011-12-31 | 6.07% |
| 2011-09-30 | 0.37% |
| 2011-06-30 | -1.09% |
| 2011-03-31 | -8.07% |
| 2010-12-31 | -6.43% |
| 2010-09-30 | -11.62% |
| 2010-06-30 | -9.39% |
| 2010-03-31 | -7.02% |
| 2009-12-31 | -17.80% |
| 2009-09-30 | -8.58% |
| 2009-06-30 | 1.86% |
| 2009-03-31 | 2.14% |
| 2008-12-31 | -11.74% |
| 2008-09-30 | -2.38% |
| 2008-06-30 | 2.90% |
| 2008-05-13 | -5.04% |
| 2007-12-31 | -41.16% |
| 2007-09-30 | -18.48% |
| 2007-06-30 | -37.59% |
| 2007-05-11 | -9.81% |
| 2006-12-31 | -22.18% |
| 2006-09-30 | 7.20% |
| 2006-06-30 | 13.56% |
| 2006-03-31 | 13.12% |
| 2005-12-31 | -40.62% |
| 2005-09-30 | -31.82% |
| 2005-06-30 | -37.40% |
| 2005-03-31 | -81.67% |
| 2004-12-31 | -211.31% |
| 2004-09-30 | -121.45% |
| 2004-06-30 | -119.31% |
| 2004-03-31 | -83.30% |
| 2003-12-31 | -93.74% |
| 2003-09-30 | -139.15% |
| 2003-06-30 | -177.84% |
| 2003-03-31 | -157.53% |
| 2002-12-31 | 2563.97% |
| 2002-09-30 | -2622.99% |
